Ohad Hammer
Net worth: - $ as of 2026-10-30
Net worth: - $ as of 2026-10-30
Ohad Hammer is currently Director at Step Pharma SAS since 2021, Director at ADCendo ApS since 2023, Independent Non-Executive Director at AgomAb Therapeutics NV since 2019, Director at Eyevensys SAS, Director at Metabomed Ltd., Non Executive Director at Precirix NV since 2018, and Partner at Pontifax Management Co. Ltd. since 2009.
Former roles include Director at TargEDys SA, Director at Keros Therapeutics, Inc., Director at Pi Therapeutics Ltd., and Member-Supervisory Board at Emergence Therapeutics AG.
Education includes graduate studies at Tel-Aviv University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-17 | 0 ( -.--% ) | - $ | 2026-10-30 |
| Companies | Position | Start |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Director/Board Member | 2019-03-31 |
Eyevensys SAS
Eyevensys SAS Pharmaceuticals: MajorHealth Technology Develops non-viral gene therapy process for the treatment of ocular illnesses | Director/Board Member | - |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment | Director/Board Member | 2018-10-31 |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Director/Board Member | - |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Director/Board Member | 2021-02-28 |
ADCendo ApS
ADCendo ApS BiotechnologyHealth Technology Operates as a clinical-stage biotech company that dedicated to developing transformative first and best-in-class antibody-drug conjugate therapies for cancers | Director/Board Member | 2023-03-31 |
Pontifax Management Co. Ltd.
Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax invests in companies located in Israel. The firm focuses on the companies operating in the fields of life sciences & health sector. The firm provide financing for early and growth stage capital transactions. | Private Equity Analyst | 2009-05-31 |
| Companies | Position | End |
|---|---|---|
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Director/Board Member | - |
| KEROS THERAPEUTICS, INC. | Director/Board Member | - |
| ░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pontifax Management Co. Ltd.
Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax invests in companies located in Israel. The firm focuses on the companies operating in the fields of life sciences & health sector. The firm provide financing for early and growth stage capital transactions. | Finance |
Eyevensys SAS
Eyevensys SAS Pharmaceuticals: MajorHealth Technology Develops non-viral gene therapy process for the treatment of ocular illnesses | Health Technology |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
TargEDys SA
TargEDys SA BiotechnologyHealth Technology Develops and manufactures nutritional solutions to control metabolic diseases | Health Technology |
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Health Technology |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment | Health Technology |
ADCendo ApS
ADCendo ApS BiotechnologyHealth Technology Operates as a clinical-stage biotech company that dedicated to developing transformative first and best-in-class antibody-drug conjugate therapies for cancers | Health Technology |
AgomAb Therapeutics NV
AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions